Chrome Extension
WeChat Mini Program
Use on ChatGLM

Musashi-2 Potentiates Colorectal Cancer Immune Infiltration by Regulating the Post-Translational Modifications of HMGB1 to Promote DCs Maturation and Migration

Cell communication and signaling : CCS(2024)

Xiamen University

Cited 1|Views20
Abstract
Post-translational modifications (PTMs) of the non-histone protein high-mobility group protein B1 (HMGB1) are involved in modulating inflammation and immune responses. Recent studies have implicated that the RNA-binding protein (RBP) Musashi-2 (MSI2) regulates multiple critical biological metabolic and immunoregulatory functions. However, the precise role of MSI2 in regulating PTMs and tumor immunity in colorectal cancer (CRC) remains unclear. Here, we present data indicating that MSI2 potentiates CRC immunopathology in colitis-associated colon cancer (CAC) mouse models, cell lines and clinical specimens, specifically via HMGB1-mediated dendritic cell (DC) maturation and migration, further contributes to the infiltration of CD4+ and CD8+ T cells and inflammatory responses. Under stress conditions, MSI2 can exacerbate the production, nucleocytoplasmic transport and extracellular release of damage-associated molecular patterns (DAMPs)-HMGB1 in CRC cells. Mechanistically, MSI2 mainly enhances the disulfide HMGB1 production and protein translation via direct binding to nucleotides 1403–1409 in the HMGB1 3′ UTR, and interacts with the cytoplasmic acetyltransferase P300 to upregulate its expression, further promoting the acetylation of K29 residue in HMGB1, thus leading to K29-HMGB1 nucleocytoplasmic translocation and extracellular release. Furthermore, blocking HMGB1 activity with glycyrrhizic acid (Gly) attenuates MSI2-mediated immunopathology and immune infiltration in CRC in vitro and in vivo. Collectively, this study suggests that MSI2 may improve the prognosis of CRC patients by reprogramming the tumor immune microenvironment (TIME) through HMGB1-mediated PTMs, which might be a novel therapeutic option for CRC immunotherapy.
More
Translated text
Key words
Musashi-2,HMGB1,Post-translational modifications (PTMs),Immune infiltration,Colorectal cancer (CRC)
PDF
Bibtex
AI Read Science
AI Summary
AI Summary is the key point extracted automatically understanding the full text of the paper, including the background, methods, results, conclusions, icons and other key content, so that you can get the outline of the paper at a glance.
Example
Background
Key content
Introduction
Methods
Results
Related work
Fund
Key content
  • Pretraining has recently greatly promoted the development of natural language processing (NLP)
  • We show that M6 outperforms the baselines in multimodal downstream tasks, and the large M6 with 10 parameters can reach a better performance
  • We propose a method called M6 that is able to process information of multiple modalities and perform both single-modal and cross-modal understanding and generation
  • The model is scaled to large model with 10 billion parameters with sophisticated deployment, and the 10 -parameter M6-large is the largest pretrained model in Chinese
  • Experimental results show that our proposed M6 outperforms the baseline in a number of downstream tasks concerning both single modality and multiple modalities We will continue the pretraining of extremely large models by increasing data to explore the limit of its performance
Try using models to generate summary,it takes about 60s
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn
Chat Paper

要点】:本研究揭示了RNA结合蛋白Musashi-2 (MSI2)通过调节非组蛋白高机动性群蛋白B1 (HMGB1)的翻译后修饰来增强结直肠癌免疫浸润,进而促进树突状细胞(DCs)的成熟和迁移。这种作用进一步促使CD4 +和CD8 +T细胞的浸润和炎症反应。

方法】:本研究使用结肠炎相关结直肠癌(CAC)小鼠模型、细胞系和临床标本,发现MSI2通过直接与HMGB1 3'UTR上的1403-1409核苷酸结合,增强二硫化HMGB1的产生和蛋白翻译,并与胞质乙酰转移酶P300相互作用,上调其表达,进一步促进HMGB1 K29残基的乙酰化,从而导致K29-HMGB1的核质转位和细胞外释放。

实验】:本研究通过使用甘草酸(Gly)阻断HMGB1活性,在体外和体内实验中发现,MSI2介导的免疫病理和免疫浸润可以得到削弱。这些结果表明,通过HMGB1介导的翻译后修饰,MSI2可以通过重编程肿瘤免疫微环境(TIME)来改善结直肠癌患者的预后,可能成为结直肠癌免疫疗法的一种新治疗选择。 数据集名称未提及。